EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Durability of transcatheter aortic valve implantation

Julien Ternacle, Sébastien Hecht, Hélène Eltchaninoff, Erwan Salaun, Marie-Annick Clavel, Nancy Côté, Philippe Pibarot

EuroIntervention · 2024-07 · 20 (14) · e845-e864

DOI: 10.4244/eij-d-23-01050 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift EuroIntervention, 2024-07. Verfasst von Julien Ternacle und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unité Médico-Chirurgicale des Valvulopathies, Hôpital Haut-Leveque, CHU Bordeaux, Pessac, France. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Heart Valve Prosthesis, Aortic Valve. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transcatheter aortic valve implantation (TAVI) is now utilised as a less invasive alternative to surgical aortic valve replacement (SAVR) across the whole spectrum of surgical risk. Long-term durability of the bioprosthetic valves has become a key goal of TAVI as this procedure is now considered for younger and lower-risk populations. The purpose of this article is to present a state-of-the-art overview on the definition, aetiology, risk factors, mechanisms, diagnosis, clinical impact, and management of bioprosthetic valve dysfunction (BVD) and failure (BVF) following TAVI with a comparative perspective versus SAVR. Structural valve deterioration (SVD) is the main factor limiting the durability of the bioprosthetic valves used for TAVI or SAVR, but non-structural BVD, such as prosthesis-patient mismatch and paravalvular regurgitation, as well as valve thrombosis or endocarditis may also lead to BVF. The incidence of BVF related to SVD or other causes is low (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementHeart Valve ProsthesisAortic ValveHumansRisk FactorsBioprosthesisAortic Valve StenosisProsthesis FailureTreatment OutcomeProsthesis DesignHeart Valve Prosthesis Implantation

Autor:innen und Institutionen

  • Unité Médico-Chirurgicale des Valvulopathies, Hôpital Haut-Leveque, CHU Bordeaux, Pessac, France.
  • Department of Cardiology, Québec Heart & Lung Institute - Laval University, Québec, Canada.
  • Department of Cardiology, University of Rouen Normandie, Inserm U1096, CHU Rouen, Rouen, France.

Zitieren

APA

Ternacle, J., Hecht, S., Eltchaninoff, H., Salaun, E., Clavel, M. A., Côté, N., & Pibarot, P. (2024). Durability of transcatheter aortic valve implantation. EuroIntervention, 20(14), e845-e864. https://doi.org/10.4244/eij-d-23-01050

Vancouver

Ternacle J, Hecht S, Eltchaninoff H, Salaun E, Clavel MA, Côté N, et al. Durability of transcatheter aortic valve implantation. EuroIntervention. 2024;20(14):e845-e864. doi:10.4244/eij-d-23-01050

BibTeX
@article{Ternacle2024,
  author = {Ternacle, Julien and Hecht, Sébastien and Eltchaninoff, Hélène and Salaun, Erwan and Clavel, Marie-Annick and Côté, Nancy and Pibarot, Philippe},
  title = {Durability of transcatheter aortic valve implantation},
  journal = {EuroIntervention},
  year = {2024},
  volume = {20},
  number = {14},
  pages = {e845--e864},
  doi = {10.4244/eij-d-23-01050}
}
Kostenlos starten →